ZCM
CSBR icon

Zebra Capital Management’s Champions Oncology CSBR Stock Holding History

Zebra Capital Management’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-32,084
Closed -$346K – 185
2020
Q4 		$346K Sell
32,084
-1,714
-5% -$17.7K 0.44% 104
2020
Q3 		$313K Buy
+33,798
New +$301K 0.48% 99

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Zebra Capital Management's CSBR Position: Q1 2021 in Review

Zebra Capital Management sold out of Champions Oncology (CSBR) in Q1 2021, closing a stake of 32,084 shares — an estimated $346K sold.

Zebra Capital Management first reported a position in CSBR in Q3 2020 and held it in 2 quarters. The position peaked at $346K in Q4 2020. 45 funds tracked by Wall St. Rank hold CSBR as of Q1 2021.

  • Zebra Capital Management reported no remaining Champions Oncology position as of Q1 2021 after selling out during the quarter.
  • Zebra Capital Management sold 32,084 Champions Oncology shares in Q1 2021, an estimated $346K.
  • Zebra Capital Management first reported a position in Champions Oncology in Q3 2020 and held it in 2 quarters.
  • Zebra Capital Management's Champions Oncology position peaked at $346K in Q4 2020.
  • 45 funds tracked by Wall St. Rank held Champions Oncology as of Q1 2021.

Based on Zebra Capital Management's 13F filing for Q1 2021, filed 17 May 2021.